Wednesday, July 8, 2026

Drug profile · INN

ibutilide fumarate

ibutilide fumarate (IBUTILIDE FUMARATE) is a herg blocker. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ibutilide fumarate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

ibutilide fumarate (IBUTILIDE FUMARATE) is a herg blocker. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN ibutilide fumarate
Brand IBUTILIDE FUMARATE
Mechanism HERG blocker
Target Voltage-gated inwardly rectifying potassium channel KCNH2
Route INJECTION
Formulation INJECTABLE

Mechanism of action

HERG blocker

Primary target: Voltage-gated inwardly rectifying potassium channel KCNH2

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. amiodarone hydrochloride HERG blocker
  2. dofetilide Cardiovascular system (C01)
  3. vernakalant hydrochloride Cardiovascular system (C01)

Frequently asked questions

What is ibutilide fumarate?

ibutilide fumarate (IBUTILIDE FUMARATE) is a herg blocker. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for ibutilide fumarate?

IBUTILIDE FUMARATE is a marketed brand name for ibutilide fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ibutilide fumarate?

ibutilide fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.